Gynecological Devices Market Boosted by AI Innovation

The global gynecological devices market size surpassed USD 10.52 billion in 2024 and is predicted to reach around USD 23.22 billion by 2034, registering a CAGR of 8.23% from 2025 to 2034.

Highlights of the Gynecological Devices Market

• By product, the surgical devices segment held a dominant presence in the market in 2024.
• By product, the diagnostic imaging systems segment is expected to experience the highest growth rate in the market between 2025 and 2034.
• By end use, the hospitals and clinics segment accounted for a considerable share of the gynecological devices market in 2024.
• By end use, the ambulatory surgical centers (ASCs) are set to experience the fastest rate of market growth from 2025 to 2034.
• North America dominated the global gynecological devices market in 2024.
• Asia Pacific is projected to host the fastest-growing market in the coming years.

Industry Valuation and Growth Rate Projection

Gynecological devices play an important role in the diagnosis, treatment, and management of many conditions affecting women’s reproductive health. These devices range from therapeutic (nonsurgical) and rehabilitative tools to surgical instruments. The importance of quality in gynecology equipment includes well-designed and reliable devices also contribute to greater efficiency and reduced intervention times. The U.S. gynecological devices market growth is driven by the introduction of technically advanced products, an increase in initiatives promoting routine checkups, and the rising prevalence of gynecological diseases.

According to a report published in 2025, the global burden of diseases (GBD) includes uterine neoplasms, in situ cervical, benign, ovarian cancer, uterine cancer, cervical cancer, genital prolapse, uterine fibroids, polycystic ovarian syndrome (PCOS), and other gynecological diseases. GBD 2021 datasets assess health loss because of 371 diseases and 88 risk factors across 204 countries since 1990, employing advanced methodologies like spatiotemporal Gaussian process regression and MR-BRT to correct biases and estimate health loss.

Gynecological Devices: Stats and Figures

• According to a report published in March 2023 by the World Health Organization (WHO), endometriosis affects roughly 10% (190 million) of reproductive-age women and girls globally.
• According to a report published in January 2024, investment addressing the women’s health gap could add years of life and life to years and potentially boost the global economy by $1 trillion annually by 2040.

How has AI Benefited the Gynecological Devices Market?

An AI algorithm analyzes medical imaging data like CT scans, MRIs, and US to detect early signs of gynecological cancers. CTG interpretation and fetal physiology can potentially be facilitated by AI, thereby limiting adverse events in obstetrics. In gynecology, AI can delineate the complexity of the molecular biology of gynecological cancer and consequently serve the vision of personalized medicine. AI-assisted tools can predict the outcomes of patients rapidly, saving time and avoiding delays in directing further care.

Industry Leader Announcements

• Wendy Brauner, Vice President, Commercial, at KARL STORZ United States

Wendy Brauner, Vice President, Commercial, at KARL STORZ United States, said, “We are excited to make this podcast available to anyone with an interest in enhancing healthcare operations for the benefit of patients everywhere.”

• Holly Sheffield, President, Cooper Surgical, Inc.

Holly Sheffield, President, Cooper Surgical, Inc., said, “We are honored to be able to support ASRM in their quest to advance the science of embryology through innovative education and training, empowering professionals to transform the future of reproductive healthcare.”

Geographical Insights

North America dominated the global gynecological devices market in 2024. Increasing use of technologically advanced products, increasing initiatives promoting routine checkups, and rising prevalence of gynecological disorders are driving the growth of the market in the North American region.

Asia Pacific is projected to host the fastest-growing market in the coming years. Rise in outpatient procedures, growing awareness of women’s health, rising prevalence of gynecological disorders, and technological advancements are contributing to the growth of the gynecological devices market in the Asia Pacific region.

Recent Developments in the Gynecological Devices Market

• In January 2025, Bioceptive and Trimedic announced a collaboration to bring the FDA-approved Cervical Suction Retractor (CSR) to market in Canada and the United States. The device offers an alternative to the traditional tenaculum used in gynecological procedures, including IUD insertion.
• In November 2024, the launch of a new maternal fetal medicine (MFM) division lead by Dan Kiefer, MD, was announced by Celebration Obstetrics & Gynecology. It is dedicated to providing specialized care for women with high-risk pregnancies.

Competitive Landscape

The gynecological devices market is moderately competitive and has a number of large and medium-scale enterprises in increasingly stiff competition for different segments of the market, such as surgical instruments, diagnostic devices, and endoscopy tools.

• Company Name: Boston Scientific Corporation
• Year of Incorporation: 1979
• Headquarters: Marlborough, Massachusetts, United States

Boston Scientific Corporation operates in about 130 countries. The multinational operates in the MedSurg, Cardiovascular, Neuro, and Rhythm sectors around the world.

• Company Name: Cooper Surgical Inc.
• Year of Incorporation: 2017
• Headquarters: Trumbull, Connecticut, United States

Cooper Surgical Inc. operates in more than 130 countries, with significant investments in women’s health and fertility sectors around the world.